Alexa

Testosterone Therapy Lawsuit Filed by South Carolina Couple

South Carolina Couple Files Lawsuit Against Pharmaceutical Companies Manufacturing Testosterone Therapy The latest of thousands of personal injury lawsuits filed against pharmaceutical companies due to testosterone therapy side effects comes from a South Carolina couple, who have both physically and emotionally suffered after one partner was … [Read more...]

Testosterone Therapy Trial Gives Mixed Results

New Testosterone Therapy Trials Show Some Good, Some Bad Results The latest in a slew of scientific studies investigating the potential dangers of testosterone therapy showed no link between healthy male adults over age 50 and cardiovascular incidents.  However, the trials also did not show a link between improved sexual function and quality of … [Read more...]

Upcoming Testosterone Therapy MDL Trial Highlights Drug Industry Issues

Testosterone Therapy MDL Will Focus on Off-Label Marketing of Fake Disease The testosterone therapy MDL (multidistrict litigation) has 1,340 personal injury lawsuits alleging that therapies like Androgel, manufactured by AbbVie, were not only misrepresented in off-label direct-to-consumer marketing, but the drug manufacturers created a fake … [Read more...]

FDA Warns Against Overuse of Testosterone Therapy

Another Warning from the FDA Chides Doctors for Over-Prescribing and Enabling Overuse of Testosterone Therapy The Food and Drug Administration has issued another warning to doctors regarding overuse of testosterone replacement therapy – the gels, pills, and ointments, the agency says, should not be overused to treat common signs of aging, such as … [Read more...]

Testosterone Therapy Not Linked to Prostate Cancer

Testosterone Therapy Does Not Lead to Prostate Cancer, Could Still Cause Cardiovascular Problems Testosterone therapy has recently been under a storm of controversy.  Reports of older men prescribed gels, pills, or creams to help treat symptoms of “low T” like fatigue or low sexual performance, have been received by the FDA and testosterone … [Read more...]

FDA Advises Testosterone Therapy Not Good for “Low T”

FDA Panel Advises Testosterone Therapy for “Low T” Needs Further Investigation When the Food and Drug Administration originally approved some types of testosterone therapy, the intended use was to treat serious hormonal disorders, such as hypogonadism. Despite this limited approval, pharmaceutical companies heavily marketed the claim that … [Read more...]

FDA Debates Use of Testosterone Therapy, Benefits, Side Effects

FDA Fails to Find Evidence That Use of Testosterone Therapy Works The Food and Drug Administration has scheduled a meeting amongst regulators to discuss the benefits and detriments of the use of testosterone therapy, in light of numerous Low T personal injury lawsuits that have recently alleged harmful side effects from using the product, … [Read more...]

Testosterone Therapy Lawsuits Consolidated in MDL

Testosterone Therapy Lawsuits Granted Federal MDL All testosterone therapy lawsuits have been consolidated into one multidistrict litigation (MDL) by the Judicial Panel of Multidistrict Litigation (JPML) due to similarities in injuries and claims against testosterone therapy manufacturers. The testosterone therapy lawsuits were consolidated in … [Read more...]

Low-T Lawsuit Prompts Continued Debate

Low-T Lawsuit Filed Against Axiron Testosterone Therapy A man in Corbin, Kentucky filed a lawsuit against the manufacturers of Axiron, a testosterone therapy, alleging that taking the drug led to his stroke. Danny L. Warren filed the low-t lawsuit against Eli Lilly, manufacturers of Axiron testosterone therapy, on June 27th in the US District … [Read more...]

FDA Enforces Warning Labels on Testosterone Therapy

FDA Requires Warnings on Testosterone Therapy About Blood Clots On Thursday, June 19th, the Food and Drug Administration (FDA) announced that it would require warning labels on testosterone therapy, including AndroGel, that would inform consumers about the risks of blood clots and strokes. Postmarket studies of blood clot and stroke risks related … [Read more...]

BestLawyers.comAVBetter Business Bureau